Medicare Enrolled

Dr. Joseph Holland, M.D.

Gastroenterology · Beaumont, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
950 N 14TH ST STE 100, Beaumont, TX 77702
4098335858
In practice since 2006 (19 years)
NPI: 1740247519 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holland? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holland

Dr. Joseph Holland is a gastroenterology in Beaumont, TX, with 19 years in practice. Based on federal Medicare data, Dr. Holland performed 1,733 Medicare services across 1,595 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holland received a total of $5,116 from 40 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holland is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in TX$ $5,116 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,733
Medicare services
Top 9% in TX for gastroenterology
1,595
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Upper GI endoscopy with biopsy300$51$680
Removal of polyps or growths of large bowel using an endoscope with mechanical snare273$193$1,067
Hospital follow-up visit, low complexity242$37$80
Insertion of guide wire with dilation of esophagus using a flexible endoscope181$101$701
Initial hospital admission, moderate complexity152$97$278
Colorectal cancer screening; colonoscopy on individual at high risk99$170$778
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope82$75$518
Colonoscopy with biopsy69$91$847
Diagnostic exam of large bowel using a flexible endoscope67$132$781
Office visit, established patient (20-29 min)55$58$148
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk40$172$781
Office visit, established patient (30-39 min)34$85$217
Diagnostic exam of lower portion of large bowel using a flexible endoscope25$34$235
Imaging of digestive tract done from the inside of the digestive tract23$550$3,755
Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope20$138$848
Injection beneath lining of large bowel using a flexible endoscope13$12$842
Insertion of stomach tube using a flexible endoscope12$137$844
New patient office visit (45-59 min)12$119$332
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes12$63$206
Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare11$120$827
Diagnostic exam of small bowel (excluding lower small intestine) using an endoscope11$107$607
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,116
Total received (2018-2024)
Avg $731/year across 7 years
Top 38% in TX for gastroenterology
40
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,000 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,051
2023
$1,659
2022
$1,162
2021
$511
2020
$73
2019
$201
2018
$458

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$945
Takeda Pharmaceuticals U.S.A., Inc.
$461
Keystone Dental Inc.
$433
Janssen Biotech, Inc.
$413
Celgene Corporation
$344
AbbVie Inc.
$197
Intuitive Surgical, Inc.
$184
Ardelyx, Inc.
$148
Ferring Pharmaceuticals Inc.
$133
Regeneron Healthcare Solutions, Inc.
$131
Ethicon US, LLC
$123
IRONWOOD PHARMACEUTICALS, INC
$108
Intercept Pharmaceuticals, Inc.
$103
PFIZER INC.
$94
AIMMUNE THERAPEUTICS, INC.
$92
Boston Scientific Corporation
$91
Phathom Pharmaceuticals, Inc.
$91
INTERCEPT PHARMACEUTICALS, INC.
$83
Braintree Laboratories, Inc.
$80
Insmed, Inc.
$75
CONMED Corporation
$72
Ironwood Pharmaceuticals, Inc
$72
E.R. Squibb & Sons, L.L.C.
$64
BOSTON SCIENTIFIC CORPORATION
$60
GENZYME CORPORATION
$59
RedHill Biopharma Inc.
$55
Merck Sharp & Dohme LLC
$55
Lilly USA, LLC
$51
Celltrion USA Inc.
$51
NESTLE HEALTHCARE NUTRITION INC.
$43
Synergy Pharmaceuticals Inc
$41
Geistlich Pharma, North America, Inc.
$32
Apollo Endosurgery US Inc
$28
Sandoz Inc.
$20
Ambu Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Organon LLC
$14
Micro-tech Endoscopy USA, Inc.
$9
GI Supply, Inc.
$4
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
AirSeal · All products · Arikayce · CONMED HEMOSTASIS · CREON · DIFICID · DUPIXENT · Da Vinci Surgical System · ENTYVIO · GATTEX · Geistlich Bio-Gide · HUMIRA · HYRIMOZ · IBSRELA · INFLECTRA · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTOFEN · OCALIVA · OMVOH · REBYOTA · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUTAB · Serrated Forcep · TREMFYA · Talicia · Trulance · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · X-Tack Endoscopic HeliX Tacking System · XELJANZ · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $295 per 100 Medicare services performed
Looking for a gastroenterology in Beaumont?
Compare gastroenterologys in the Beaumont area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
11
Per 100K population
4.3
County median income
$59,934
Nearest hospital
CHRISTUS SOUTHEAST TEXAS- ST ELIZABETH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Holland is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Holland experienced with upper gi endoscopy with biopsy?
Based on Medicare claims data, Dr. Holland performed 300 upper gi endoscopy with biopsy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holland receive payments from pharmaceutical companies?
Yes. Dr. Holland received a total of $5,116 from 40 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holland's costs compare to other gastroenterologys in Beaumont?
Dr. Holland's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →